Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
Anchalee Avihingsanon(Chulalongkorn University), Taisheng Li(Peking Union Medical College Hospital), Ellen Koenig(Instituto Dermatológico y Cirugía de Piel "Dr. Huberto Bogaert Díaz"), Hal Martin(Gilead Sciences (United States)), Khuanchai Supparatpinyo(Chiang Mai University), Fujie Zhang(Capital Medical University), Chien‐Ching Hung(National Taiwan University), Jared M. Baeten(University of Washington), Sasisopin Kiertiburanakul(Ramathibodi Hospital), Jason T. Hindman(Gilead Sciences (United States)), Hongzhou Lu(Southern University of Science and Technology), Hongyuan Wang(Beijing Institute of Technology), Sophia Rahman(Gilead Sciences (United States)), Michelle L. D’Antoni(Gilead Sciences (United States)), Chee Loon Leong, Man‐Po Lee(Queen Elizabeth Hospital)
Cited by 62
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
|New England Journal of Medicine|2010|532
Infection with <i>Trichomonas vaginalis</i> Increases the Risk of HIV‐1 Acquisition
|The Journal of Infectious Diseases|2007|481